microRNA-181d associated with the methylation status of the MGMT gene in Glioblastoma multiforme cancer stem cells submitted to treatments with ionizing radiation and temozolomide-Reference-Cited by-同舟云学术

microRNA-181d associated with the methylation status of the MGMT gene in Glioblastoma multiforme cancer stem cells submitted to treatments with ionizing radiation and temozolomide

Published:2019-10 Issue: Volume:1720 Page:146302
ISSN:0006-8993
Container-title:Brain Research
language:en
Short-container-title:Brain Research

Author:

Lizarte Neto Fermino Sanches,Rodrigues Andressa Romualdo,Trevisan Felipe Amstalden,de Assis Cirino Mucio Luiz,Matias Caio César Marconato Simões,Pereira-da-Silva Gabriela,Peria Fernanda Maris,Tirapelli Daniela Pretti da Cunha,Carlotti Jr. Carlos Gilberto

Funder

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Publisher

Elsevier BV

Subject

Developmental Biology,Neurology (clinical),Molecular Biology,General Neuroscience

Reference30 articles.

1. Therapeutic implications of cancer stem cells;Al-Hajj;Curr. Opin. Genet. Dev.,2004

2. MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients;Brandes;J. Clin. Oncol.,2008

3. MicroRNAs in cancer: glioblastoma and glioblastoma cancer stem cells;Brower;Neurochem. Int.,2014

4. Targeted therapeutics in patients with high-grade gliomas: past, present, and future;Chen;Curr. Treat. Options Oncol.,2016

5. The many functions of microRNAs in glioblastoma;Chiocca;World Neurosurg.,2010

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular landscape of glucose metabolism in glioblastoma and the normal human brain: A narrative review;Glioma;2024-04

2. Non-coding RNAs and glioma: Focus on cancer stem cells;Molecular Therapy - Oncolytics;2022-12

3. MicroRNA-628-3p inhibits glioblastoma cell proliferation and GSC maintenance by directly targeting BTK;2022-11-09

4. N6-methyladenosine-related microRNAs risk model trumps the isocitrate dehydrogenase mutation status as a predictive biomarker for the prognosis and immunotherapy in lower grade gliomas;Exploration of Targeted Anti-tumor Therapy;2022-09-30

5. Epigenetic modulators for brain cancer stem cells: Implications for anticancer treatment;World Journal of Stem Cells;2021-07-26